Company profile
SimBioSys, Inc.
SimBioSys, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on December 26, 2023 and the most recent on July 8, 2025 (TumorSight Viz). Its most common review panel is Radiology (3 devices).
3AI devices
2023First decision
2025Latest decision
1Specialties
Per year
202320242025
By specialty
Related guides
Timeline
- TumorSight Viz · Radiology · QIH
- TumorSight Viz · Radiology · QIH
- TumorSight Viz · Radiology · QIH